EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of wires or leads; and SOLVE-CRT, an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

Sector

Healthcare

Industry

Medical - Devices

CEO

McCutcheon, John

Employees

Website

www.ebrsystemsinc.com

IPO Date

2021-11-23

Headquarters

480 Oakmead Parkway, Sunnyvale, California, 94085, United States

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

EBR Systems EBR

EBR Systems Earnings Call Summary

EBR Systems Earnings

Transcripts

Events

About EBR Systems, Inc.

EBR Systems
EBR